Literature DB >> 20511702

Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications.

Xiaobin Luo1, Haijun Zhang, Jiening Xiao, Zhiguo Wang.   

Abstract

Excitability is a fundamental characteristic of cardiac cells, which is delicately determined by ion channel activities modulated by many factors. MicroRNA (miRNA) expression is dynamically regulated and altered miRNA expression can render expression deregulation of ion channel genes leading to channelopathies-arrhythmogenesis. Indeed, evidence has emerged indicating the crucial role of miRNAs in controlling cardiac excitability by regulating expression of ion channel genes at the post-transcriptional level. However, the very limited experimental data in the literature hinder our understanding of the role of miRNAs and the often one-to-one interaction between miRNA and ion-channel gene in the published studies also casts a doubt about fullness of our view. Unfortunately, currently available techniques do not permit thorough characterization of miRNA targeting; computational prediction programs remain the only source for rapid identification of a putative miRNA target in silico. We conducted a rationally designed bioinformatics analysis in conjunction with experimental approaches to identify the miRNAs from the currently available miRNA databases which have the potential to regulate human cardiac ion channel genes and to validate the analysis with several pathological settings associated with the deregulated miRNAs and ion channel genes in the heart. We established a matrix of miRNAs that are expressed in cardiac cells and have the potential to regulate the genes encoding cardiac ion channels and transporters. We were able to explain a particular ionic remodeling process in hypertrophy/heart failure, myocardial ischemia, or atrial fibrillation with the corresponding deregulated miRNAs under that pathological condition; the changes of miRNAs appear to have anti-correlation with the changes of many of the genes encoding cardiac ion channels under these situations. These results indicate that multiple miRNAs might be critically involved in the electrical/ionic remodeling processes of cardiac diseases through altering their expression in cardiac cells, which has not been uncovered by previous experimental studies. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511702     DOI: 10.1159/000315076

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  33 in total

1.  KCNE2 protein is more abundant in ventricles than in atria and can accelerate hERG protein degradation in a phosphorylation-dependent manner.

Authors:  Mei Zhang; Yuhong Wang; Min Jiang; Dimitar P Zankov; Sabeeha Chowdhury; Vigneshwar Kasirajan; Gea-Ny Tseng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

2.  Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.

Authors:  S Suffredini; F Stillitano; L Comini; M Bouly; S Brogioni; C Ceconi; R Ferrari; A Mugelli; E Cerbai
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

Review 4.  Role of circular RNAs in cardiovascular diseases.

Authors:  Xue Gong; Gengze Wu; Chunyu Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

5.  Roles of MicroRNA-195 in cardiomyocyte apoptosis induced by myocardial ischemia-reperfusion injury.

Authors:  Chang-Kui Gao; Hui Liu; Cheng-Ji Cui; Zhao-Guang Liang; Hong Yao; Ye Tian
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

6.  Function and evolution of a MicroRNA that regulates a Ca2+-ATPase and triggers the formation of phased small interfering RNAs in tomato reproductive growth.

Authors:  Ying Wang; Asuka Itaya; Xuehua Zhong; Yang Wu; Jianfeng Zhang; Esther van der Knaap; Richard Olmstead; Yijun Qi; Biao Ding
Journal:  Plant Cell       Date:  2011-09-13       Impact factor: 11.277

7.  MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation.

Authors:  Xiaobin Luo; Zhenwei Pan; Hongli Shan; Jiening Xiao; Xuelin Sun; Ning Wang; Huixian Lin; Ling Xiao; Ange Maguy; Xiao-Yan Qi; Yue Li; Xu Gao; Deli Dong; Yong Zhang; Yunlong Bai; Jing Ai; Lihua Sun; Hang Lu; Xiao-Yan Luo; Zhiguo Wang; Yanjie Lu; Baofeng Yang; Stanley Nattel
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

Review 8.  Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.

Authors:  Jared W Magnani; Michiel Rienstra; Honghuang Lin; Moritz F Sinner; Steven A Lubitz; David D McManus; Josée Dupuis; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2011-11-01       Impact factor: 29.690

9.  MiR-20 regulates myocardiac ischemia by targeting KATP subunit Kir6.1.

Authors:  Li Nie; Ya-Nan Zhao; Hong-Yan Luo; Xin-Wu Hu; Liang-Pin Zhang; Hua-Min Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 10.  MicroRNAs and atrial fibrillation: mechanisms and translational potential.

Authors:  Xiaobin Luo; Baofeng Yang; Stanley Nattel
Journal:  Nat Rev Cardiol       Date:  2014-11-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.